Fingerprinting severe asthma

Symposium
Chairs: Sally Wenzel (Pittsburgh, United States of America), Craig Wheelock (Stockholm, Sweden)
Aims: The UBIOPRED project (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) aims to increase our understanding of the different types of severe asthma by defining biomarkers for severe asthma. For this, a large cohort and a multi-omics approach is being employed. The resulting huge database can be used to stratify patients according to phenotypes or clusters; identify individual biomarkers of disease by using readily accessible samples; define single molecular fingerprints by using 'omics technologies; and integrate clinical, biomarker, and 'omics approaches to obtain individualised disease signatures or handprints.
Target audience: Clinicians, scientists, clinical scientists, cell and molecular biologists, and translational researchers.
Introduction to the UBIOPRED project
Peter Sterk (Amsterdam, Netherlands)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Defining the clinical clusters of severe asthma within UBIOPRED
Marijke Amelink (Amsterdam, Netherlands)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Integrating fingerprints: molecular phenotyping of severe asthma
Bertrand De Meulder (Lyon, France)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Severe asthma in children
Louise Fleming (London, United Kingdom)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Patient's testimonial
Breda Flood (Gorey, Ireland)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files